Study on nava kashaya and shirisha twak lepa on dadru Kustha(tinea corporis)

An open labeled randomized double armed controlled clinical study on Nava Kashaya and Shirisha Twak Lepa on Dadru Kustha w.s.r Tinea corporis - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/057005

Enrollment

Registered

2023-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group between 21-60yrs fulfilling diagnostic criteria irrespective of gender, religion, and socio-economic status. Sub categorization of age from 21-30yrs, 31-40yrs, 41-50yrs, 51-60yrs will be done. 2.Patients having signs & symptoms of Dadru Kustha(Tinea corporis). 3.Patients having chronicity less than 3yrs 4.Distribution of skin lesions on waistline, axillae, buttocks, other parts of the trunk, extremities. 5.Patients having positive results for Potassium Hydroxide (KOH) examination of skin scraping & fungal culture by Sabouraud’s medium 6.Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Patients aged below 20yrs & above 60yrs 2.Patients having chronicity of more than 3yrs 3.Distribution of skin lesions on palms, soles, groins 4.Patients of Psoriasis, Discoid Eczema, Atopic Dermatitis, Pityriasis Rosea, Secondary Syphilis, Tinea Versicolor, Tuberculoid Leprosy, Intertrigo with Scabies will be excluded based on clinical features 5.Systemic diseases, auto immune diseases - Diabetes Mellitus, Multiple Sclerosis, Arthritis, AIDS, Obesity . 6.Currently on mediations- usage of recurrent immune suppressants (corticosteroids) 7.Pregnant women & lactating mothers

Design outcomes

Primary

Measure	Time frame
Assessment of significant improvement in the clinical features of Dadru Kustha( Tinea corporis) based on grading of clinical features, DLQI, Wallace rules of ninesTimepoint: from the baseline of the study until the follow up period i.e. day 45	—

Secondary

Measure	Time frame
Assessment of contribution & prevention of the etiological factors in the development of pathogenesis & recurrence of Dadru Kustha (Tinea corporis)Timepoint: from the baseline of the study until the follow up period i.e. day 45	—

Countries

India

Contacts

Public ContactRashmi B V

Rajiv Gandhi University of Health Sciences Bengaluru

drrashmibv@sdmayurbangalore.in9739566112

Outcome results